Rio Tinto Ltd
RIO
BHP Group Ltd
BHP
Fortescue Ltd
FMG
ANZ Group Holdings Ltd
ANZ
Woodside Energy Group Ltd
WDS
AU Stock MarketDetailed Quotes
RAD Radiopharm Theranostics Ltd
- 0.034
- +0.010+41.67%
20min DelayTrading Jan 10 15:23 AET
74.82MMarket Cap-0.27P/E (Static)
0.038High0.032Low81.08MVolume0.035Open0.024Pre Close2.90MTurnover0.09752wk High5.29%Turnover Ratio2.20BShares0.02152wk Low-0.124EPS TTM52.14MFloat Cap0.495Historical HighLossP/E (Static)1.53BShs Float0.021Historical Low-0.124EPS LYR25.00%Amplitude--Dividend TTM2.62P/B1Lot Size--Div YieldTTM
About Radiopharm Theranostics Ltd Company
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.
Company Profile
SymbolRAD
Company NameRadiopharm Theranostics Ltd
Founded2021
MarketASX
Fiscal Year Ends06-30
Address62 Lygon Street Level 3, Carlton South
CityMelbourne
CountryAustralia
Zip Code3053
Phone+61 398245254
Share RegistryAUTOMIC REGISTRY SERVICES
Level 5, 126 Phillip Street, SYDNEY, NSW, AUSTRALIA, 2000
02 9698 5414
Company Executives
- Name
- Position
- Salary
- Riccardo Canevari
- Chief Executive Officer and Managing Director
- --
- Phillip A. Hains
- Director, Chief Financial Officer and Company Secretary
- --
- Dr. Thomas H. Tulip
- Chief Business Officer
- --
- Dr. Dimitris Voliotis, M.D.
- Chief Medical Officer
- --
- Paul E Hopper
- Executive Chairman of the Board
- --
- Ian Turner
- Director
- --
- Dr. Leila Alland, M.D.
- Director
- --
- Noel Donnelly, M.B.A.
- Independent Director
- --
- Hester Larkin
- Independent Director
- --